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Infection: the neglected paradigm in SIDS research
Paul Nathan Goldwater
ABSTRACT
Despite decades of investigation and millions of dollars
spent, the cause of sudden infant death syndrome (SIDS)
eludes researchers. It is timely therefore to reconsider the
reasons for this failure and to explore how research
might go forward with better prospects. This review
assesses SIDS research in the context of
clinicopathological and epidemiological features and
determines that only infection attains congruence.
INTRODUCTION
Despite decades of investigation and millions of
dollars spent, the cause(s) of sudden infant death
syndrome (SIDS) eludes researchers. It is timely
therefore to reconsider the reasons for this failure
and to explore how research might go forward
with better prospects.
SIDS is defined as the unexpected death of an
infant <1 year of age, with onset of the fatal
episode apparently occurring during sleep, that
remains unexplained after a thorough investigation,
including performance of a complete autopsy and
review of the circumstances of death and the clin-
ical history.1 The ‘triple risk’ hypothesis accommo-
dates multiple aetiologies (it proposed that SIDS
occurs in infants with latent biological vulnerabil-
ities, exposed to external threats during a critical
period in development).2 It has served as a basis to
tackle the problem. Mainstream research has been
undertaken on grounds that generally fail to
accommodate all aspects of the epidemiology
(encompassing the SIDS risk factors) (box 1) and
clinicopathology of SIDS (box 2). Mainstream
researchers have tended to settle on hypotheses
that lack broad-based considerations.
What are the established facts in SIDS? These
have been established through numerous epidemio-
logical investigations and reports of the gross and
microscopic pathological findings. To successfully
investigate a disease of unknown causation, it is
essential that all of these ‘facts’ are taken into
consideration.
The list of epidemiological associations shows
that infection is a key potential contender in the
causation stakes. Male gender predominance,
winter seasonality, a vulnerable host (prematurity,
genetic predisposition through important inflam-
matory, innate and adaptive immune response poly-
morphisms), pre-natal and post-natal exposure to
smoke, low socioeconomic status and so forth, all
fit an infection model. Congruence between the
increased risk of prone sleep position and infection
is supported by the increased risk of putting down
the infants to sleep on contaminated surfaces. SIDS
cases are unusual in showing colonisation by coli-
forms in the respiratory tract17–19 and by toxigenic
organisms such as Staphylococcus aureus in the
gut.13 Respiratory tract colonisation by coliforms in
SIDS carries an OR of 29 compared with healthy
age-matched infants. Reasons for these colonisation
features would seem to relate to prone sleep pos-
ition enhancing ingestion/inhalation of bacteria on
the sleeping surface especially because bacterially
contaminated surfaces (sofas, previously used
mattresses, parental bed,) are all risk factors for
SIDS.5 14 20 21 Notably the risk of SIDS is increased
by exposure to smoke while sleeping in the parental
bed.15 Also of note, smoking mothers increase the
risk of bacterial and/or viral colonisation in their
infants.17 22
AUTOPSY FINDINGS
At autopsy, there may be frothy white or blood-
stained secretions at the nares suggestive of
pulmonary oedema.23 There is some evidence to
indicate a febrile episode prior to death given that
the core temperature is frequently elevated22 and
clothing may be sweat-soaked.24
The bladder is usually empty.23 Agonal processes
or anuria secondary to hypotensive shock as part of
septic shock have been proposed.
Characteristic internal findings are exemplified
by the triad of intrathoracic petechial haemorrhages
involving the thymus, visceral pleura and epicar-
dium. In most studies, ≥90% have the petechial
triad. Notably the type and distribution of the
petechiae differ significantly from those found in
cases of asphyxia.25 26 Mainstream researchers
attribute intrathoracic petechiae to changes in pul-
monary pressure; however, this hypothesis does not
stand up to scrutiny as argued in previous publica-
tions.27–29 Studies by Krous et al30 31 disproved an
association between intrathoracic petechiae and
prone position, indicating that hypothetical upper
airway obstruction attributable to face-down pos-
ition is not causally related to development of
intrathoracic petechiae.
The lungs are congested and heavy23 indicating
pulmonary oedema/early shock lung as may occur
in septic shock. Cardiogenic causes of lung changes
(eg, left ventricular failure, non-shock) would also
fit.
Brain weight (and head circumference) is greater
in SIDS cases than comparisons32–37 and is
acknowledged by the National Institute of Child
Health and Human Development (NICHD).38
Thymomegaly in SIDS has been the subject of
considerable debate and has not yet been resolved
satisfactorily.
The kidneys39 and heart40 are lighter than
normal. These could also reflect intrauterine
growth abnormalities incorporating biological vul-
nerability (as above).
The blood within the chambers of the heart is
liquid/unclotted in almost every case.23
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Histopathology shows mild inflammatory changes within the
lungs (reflecting recent viral infection) in a large proportion of
cases.41 42 The brainstem may show subtle changes in a minority
of cases (discussed below). The intestine may show inflamma-
tory or other changes;43 pathologists often report autolytic
change. Reports of cardiomyocyte44 and diaphragm myocyte
changes have been demonstrated45 but do not seem to have
been corroborated. Evidence of a systemic inflammatory event is
present in some cases of SIDS (discussed below).
CLINICAL FINDINGS
Poets44 has provided several important clues to understanding
the aetiopathogenesis of SIDS. Babies whose moment of death
was captured on memory monitors showed a progressive
decrease in heart rate, which developed over minutes or hours.
A total of 14 recordings are published.46–52 Witnessed cases
have been reported.53
Poets54 concluded that none of the recordings showed evi-
dence of the occurrence of prolonged central apnoea as the
primary cause of death. The exact cause(s) of the bradycardia
could not be determined from the recordings, but there is evi-
dence from similar recordings that have been obtained during
apparent life-threatening events and which included data on
oxygenation that showed progressive heart rate slowing was
probably due to hypoxic cardiac depression.55–58 In the moni-
tored SIDS cases, breathing continued in the form of gasping
and followed cardiac standstill. Hypoxaemia as part of the lethal
episode in SIDS seems to be well accepted; however, the cause
of hypoxaemia deserves reconsideration. One important cause
seemingly overlooked by mainstream researchers is infection
and sepsis.
Inflammatory markers in SIDS
C reactive protein is not consistently detected or elevated41 59
In her review, Blood-Siegfried60 assembled convincing autopsy
and other evidence of infection and inflammatory responses in
SIDS. Similarly, Blackwell et al61 summarised the evidence in
terms of risk factors and specific tissue and serum findings of
inflammatory markers. Both reviews confirm strong links
between infection/inflammation and SIDS. Some of the evidence
is contained in studies of genes involved in inflammatory
Box 1 Epidemiological associations/risk factors for
sudden infant death syndrome (SIDS)
▸ Genetic predisposition (intrinsic) factors3 4
– Gender (and possible X-linked genetic mutations/copy
number variations, etc)
– Genetic control innate and adaptive immunity,
inflammatory response
– Genetic control of nitric oxide synthetase 1 (NOS1)
– Genetic control of brainstem function
– Genetic control of metabolic pathways, for example,
flavin-monooxygenase 3, an enzyme metabolising nicotine




– Low socioeconomic status7
– High birth order/previous live births8
▸ Prenatal risks9 10
– Poor prenatal care
– Maternal smoking/nicotine use
– Inadequate prenatal care
– Inadequate prenatal nutrition
– Maternal misuse of heroin, cocaine and other drugs
– Subsequent births less than 1 year apart
– Alcohol use
– Infant being overweight
– Mother being overweight
– Teen pregnancy (if the baby has a teen mother, it has a
greater risk)




– Viral respiratory or gastrointestinal symptoms in the days
before death
– Prematurity10
– Low birth weight
– Exposure to tobacco smoke
– Prone sleep position (lying on the abdomen)
– Sleeping prone while intestinally colonised with
Staphylococcus aureus.13
– Not breastfeeding
– Elevated or reduced room temperature
– Excess bedding, clothing, soft sleep surface and stuffed
animals
– Co-sleeping with parents or other siblings
– Sofa-sleeping
– Sleeping on a used mattress14
– Sleeping in parental bed15
– Infant’s age (incidence rises from zero at birth, is highest
from 2 to 4 months and declines towards zero at 1 year)
– Prematurity (increases risk of SIDS death by about four
times)
– Probable anaemia11 (haemoglobin cannot be measured
postmortem)
– Early cord clamping? (possibly causing anaemia)
– Recent visit to general practitioner/outpatient clinic
– No or late immunisation16
– Day care attendance
– Night-time death
Box 2 Pathological findings
Raised core (rectal) temperature
Frothy exudate at nares




Light heart and kidneys
Heavy congested lungs
Mild acute inflammatory changes in airways, lungs and
myocardium
Liquid/unclotted blood in chambers of heart
Empty bladder
Normally sterile site yielding a bacterial pathogen
Proteomic and immunohistochemical evidence of infection
(acylcarnitine, CD68, intercellular adhesion molecule-1, etc)
768 Goldwater PN. Arch Dis Child 2017;102:767–772. doi:10.1136/archdischild-2016-312327
Review
 on 15 M












responses. Examples include a tumour necrosis factor-α poly-
morphism responsible for high cytokine production62 and an
interleukin (IL)-1α polymorphism in parents of SIDS babies
associated with an exaggerated response to toxic shock syn-
drome toxin.63 Others include an IL-6 polymorphism
(IL-6-174G/C), associated with specific ethnic background of
SIDS cases64 and a number of IL-10 polymorphisms associated
with population-specific variations in polymorphisms and indi-
cate other risk factors must also play a role.65–67
MICROBIOLOGY
As mentioned above unusual colonisation by coliforms and toxi-
genic organisms is a feature of SIDS13 17–19 and goes some way
to explain the risk factor of prone sleep position particularly in
relation to the heightened risk associated with contaminated
sleeping surfaces.5 14 20 21 At autopsy normally sterile sites
(heart chamber blood, spleen, cerebrospinal fluid) may contain a
bacterial pathogen (eg, S aureus, Escherichia coli, other coli-
forms) in about one-fifth of cases.19 68 This could represent
a footprint of a lethal bacteraemic episode. Coliforms and
S aureus are isolated from the lungs and airways more fre-
quently from SIDS cases than non-SIDS deaths.19 68
Evidence of viral infection involving the airways, lungs, heart
and the small intestine is relatively common.41 4243 As men-
tioned above, maternal smoking promotes viral colonisation in
their infants.15 17 22
New technology including proteomics is helping in identify-
ing the role of infection in SIDS. The Great Ormond Street
Hospital group, which used tandem mass spectrometry, could
not distinguish SIDS from autopsy-proven infection-related
deaths on the basis of acylcarnitine and other related com-
pounds associated with infection,69 which strongly indicated
that infection was temporally related to SIDS deaths and sup-
ports the infection hypothesis of SIDS aetiopathogenesis.
THE MICROBIOME AND SIDS
Early studies show differences between the gut microbiome of
SIDS babies compared with healthy babies13 70 The study by
Highet and Goldwater13 goes some way to explain the risk
factor of prone sleep position with an infinitely high OR for the
occurrence of gut colonisation with S aureus and prone position
of infants when found. S aureus (frequently enterotoxigenic)
seems to more commonly colonise babies’ intestines in the first
year of life while E coli colonisation is on the decline.71
Extraintestinal E coli are frequently found in SIDS babies72 and
are isolated from normally sterile sites and often from the
airways and lungs in SIDS babies and rarely in non-SIDS
cases.19 68
α-Haemolysin (HLyA)-producing uropathogenic E coli strains
causing urinary tract and other extraintestinal infections are
found more frequently in SIDS infants compared with healthy
babies or non-SIDS deaths72 and serotypes O1:H-, O1:H5, O2:
H1, O4:H5, O6:H1, O25:H1 and O75:H5 are over-represented
in SIDS.72 Bücker et al73 found that α-HLyA of E coli triggers
intestinal inflammation in mouse models of inflammatory bowel
disease by impairing the intestinal barrier and thereby intensify-
ing antigen uptake. Such a mechanism could operate in SIDS
wherein an inflamed gut mucosa could promote microbial trans-
location into the bloodstream and cause overwhelming sepsis.74
New information showing an otherwise previously unknown
microbiome of the airways and lungs could also involve predis-
position to abnormal inflammatory responses.75
Metagenomics reveals additional data indicating the import-
ance of gut microbiome dysbiosis in relation to development of
disease such as obesity, type 1 diabetes, colitis and metabolic
syndrome.76 A preliminary metagenomics study by Leong
et al70 has demonstrated a significant association between
Anaerostipes and SIDS but previously shown associations
between S aureus, E coli and Clostridia was not corroborated in
this small sample (29 SIDS; 21 controls).
CLOTTING SYSTEM IN SIDS
The blood within the chambers of the heart is liquid/unclotted23
and remains unexplained; however, raised fibrin degradation
products (FDPs) are characteristic of SIDS.77 Evidence of disse-
minated intravascular coagulopathy (DIC) is usually not found.
While the intrathoracic petechial haemorrhages could represent
a distinct vasculopathy, linking this to raised FDPs has not yet
been established. Systemic infection is recognised as being
linked to elevated FDPs without the development of DIC. The
question remains as to the underlying reasons for raised FDPs in
SIDS. Abnormally increased FDPs are an indication of increased
fibrinolytic activity and are not specific to DIC.78
CRITIQUE OF MAINSTREAM APPROACH
Mainstream researchers have tended to focus on a single patho-
logical finding and have developed hypotheses centred on this
while tending to ignore the epidemiology/risk factors or the
other clinicopathological findings. Examples include intrathor-
acic petechiae as the basis for an asphyxial event.30 Evidence to
support this idea is either lacking or raises serious questions; for
instance, why is the distribution and number of petechiae
affected by the age, ethnicity, parity, exposure to cigarette
smoke and the sleep position?25 26 Or why infants placed prone
show a reduced frequency of pleural petechiae?25
Another major area of mainstream research focuses on brain-
stem, limbic forebrain and hippocampus and possible central
homeostatic control. Isolated pathological findings (such as
hypoplasia of the arcuate nucleus (respiratory chemosensitive
zone of the ventral medulla) and gliosis of cerebral white
matter)79 occur only in a minority of cases. This focus, limited
to a single anatomical site, ignoring overall morbid pathology or
epidemiological associations leaves the hypothesis wanting in
many respects. Similarly wanting are research paths taken based
on a single finding such as prone position found, head covered
by bedding, sleeping and dying in the parental bed (overlying).
Other researches have centred on the heart, given that adult
sudden deaths have been attributed to cardiac dysrhythmia such
as QT interval genetic pathology and other causes of channelo-
pathy80–84 or brainstem dysfunctional control. Genetically
diagnosed channelopathies are found in a minority of SIDS
cases. The finding does not necessarily mean the inherited chan-
nelopathy actually caused the deaths. Nor does anatomical
abnormality of brainstem neuronal nuclei necessarily relate to
causation of death, given that similar findings are observed in
brainstems of non-SUDI deaths, although in a smaller propor-
tion.79 These hypotheses are speculative and lethality is not
necessarily established in relation to the purported underlying
problem nor have animal models provided clear answers.
A major failing of mainstream investigations is the rarity of
inclusion of general autopsy findings in their publications that
could otherwise provide useful information. We are not privy to
the intrathoracic findings or nature of the heart blood (clotted/
unclotted) or organ weights of cases reported, for example, in
relation to hypotheses based on brainstem or cardiac aetiologies.
If pertinent information were published, it could become clearer
that purported cardiac channelopathies were associated with a
specific pathological picture, for example, absent intrathoracic
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petechiae that could help explain the <10% of SIDS cases
lacking the typical pathological findings (triad of petechiae,
liquid cardiac blood, large brain, heavy wet lungs, etc).
POSSIBLE LETHAL PROCESS
Male gender is a risk factor for almost all infections85 (pertussis
being the exception). Akin to infection, X-linked genetic suscep-
tibility would apply in the instance of SIDS.85 In consideration
of a lethal process that would fit with the epidemiology and clin-
icopathological findings there would appear to be only one—
that is bacterial infection and overwhelming sepsis/septic shock.
This is not a new proposal; Morris et al86 provided the common
bacterial toxin hypothesis encompassing sepsis and/or toxic
shock. Other groups accept and explore this approach.87–94
These authors have shown that toxigenic organisms notably
ones normally considered non-pathogenic commensals may well
have an important role in SIDS pathogenesis. Bacterial infection
accompanied by viral infection may exacerbate the effects of
bacterial infection.91 Similarly, dual bacterial infection produces
a lethal synergy.93 Bacterial infection and septic shock is often
difficult to diagnose in life as it is at autopsy.95 In a vulnerable
host, death from sepsis can be rapid and can be missed at
autopsy. Rapid-onset sepsis and death may not leave the hall-
marks of infection and there may be no features of sepsis appar-
ent at autopsy except for bacteria in normally sterile sites in
some cases. CD68 cells and other markers of infection are not
consistently found in the lungs of SIDS cases96 and may reflect
the rapid nature of the septic process before conscription of suf-
ficient immune cells to be left as a marker. The immature
immune system of neonates who have died of confirmed sepsis
show extremely variable innate and adaptive immune responses.
Indeed many infants have no evidence of CD68 or CD54 cells
in their lungs or other tissues. Intercellular adhesion molecule-1
(ICAM-1, CD54) is a cell surface protein that is expressed at
very low levels on pulmonary endothelium, lymphocytes and
macrophages. Expression of ICAM-1 is upregulated on stimula-
tion by inflammatory mediators such as cyto-ICAM-1 that
mediate inflammatory responses by adhesion of leucocytes to
activated endothelium and subsequent leucocyte translocation
through the pulmonary endothelial layer.96
Doberentz et al97 examined CD45RO, CD68 and leucocyte
common antigen-positive cells in pulmonary tissue and the cell
adhesion molecules E-selectin, P-selection and ICAM-1 and
found no difference between SIDS and non-SIDS cases. The
lack of a consistent finding reflects the situation of suspected
fatal sepsis wherein the microscopic autopsy lung findings may
be minimal, non-specific or unconvincing. Confounding our
understanding is the lack of detailed published pathological
information with respect to the existence or otherwise of
intrathoracic petechiae and liquid heart blood in cases of fatal
neonatal sepsis.
CONCLUSION
Mainstream researchers propose multiple causes of SIDS to
accommodate the several organ system-based lines of research
(box 3). If multiple causes were involved, then it would be rea-
sonable to expect a variety of pathological findings. This dem-
onstrably is not the case. There is a fixed pattern to the vast
majority of cases. The crux of the argument against broad poly-
causality of SIDS is the consistent pathological picture (usually
in more than 90% of cases). Given this consistency of patho-
logical findings and their congruency with the SIDS risk factors
and giving due acknowledgement to Occam, it is logical to
hypothesise a ‘single’ causal mechanism for those 90%. As
indicated above, deaths from possible causes which form only a
tiny minority of SIDS cases (eg, channelopathies) may not
exhibit the classical pathology of SIDS and therefore provide an
explanation for ‘different’ pathological findings such as the
absence of intrathoracic petechiae or the finding of normal
organ weights. It is therefore essential that the overall patho-
logical findings of suspected channelopathy or brainstem path-
ology cases are published. Inclusion of the epidemiological
features is also desirable.
In moving forward, SIDS researchers should be asking the fol-
lowing questions: (1) Does my hypothesis take into account the
key pathological findings in SIDS? (2) Is my hypothesis congru-
ent with the key epidemiological risk factors? (3) Does the
hypothesis link questions (1) and (2)? This review has shown
that infection meets these questions appropriately and research-
ers in this area deserve acknowledgement and funding support.
There remain gaps in our knowledge with regard to the infec-
tion model, but it is clear that other lines of research are not
making the grade. How the microbiome shapes the immune
system in infancy98 could be the key in the SIDS story especially
in relation to host pathogen recognition and vulnerability. It is
hoped that in future we will see support and action in line with
a more enlightened approach to solving the tragic enigma of
SIDS.
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